-=Adamis Pharma (ADMP) : opioid overdose treatment gets FDA approval

 

Adamis Pharma announces that the U.S. Food and Drug Administration has approved Adamis' ZIMHI 5 mg/0.5 mL product

ZIMHI is a high-dose naloxone injection product FDA-approved for use in the treatment of opioid overdose.